Molekule
Molekule began in San Francisco in 2014 with a vision to revolutionize air purification, and bring clean air to everyone, everywhere. Jaya Rao is our current CEO, and Dilip Goswami is president and CTO, and both of them are Molekule co-founders. As a child, Molekule co-founder Dilip Goswami had severe asthma and allergies. His father, Molekule co-founder Dr. Yogi Goswami, was frustrated by the lack of options for addressing poor indoor air quality. After more than 25 years of research and development, Dr. Goswami and his team decided to bring this groundbreaking technology to consumers for the first time. Both Goswami and Rao are Stanford engineers on a mission to provide better indoor air to everyone who needs it. Our breakthrough methods are fundamentally different from traditional filtration. Rather than trap particles in a filter, Molekule’s patented PECO technology destroys pollutants at the molecular level. Rigorous testing at a multitude of independent, third-party laboratories has carefully tracked and measured the destruction of particles by PECO technology. This is on top of the research Dr. Yogi Goswami did between 2006 and 2015 before helping found Molekule, when he published over 23 reports on this work. While many feel comfortable in their homes, the reality is that indoor air is often stagnant and full of particles. The World Health Organization has noted that 9 out of ten people throughout the world are breathing polluted air — indoors and out. Here at Molekule, we are on a mission to change the current realities for homes, businesses, schools, hospitals, the hospitality industry, and more. After more than 25 years of research and development work, Molekule has made even larger strides in PECO technology and air purification. In 2019, we launched Air Mini to provide a smaller standalone unit at a lower price point for rooms of less than 250 square feet. From dander particles to pollen, there are all kinds of tiny molecules that float in the air and get trapped in homes. In September 2020, we announced our new Air Pro purifier, which has increased airflow, six speed settings, and a particle sensor. The Molekule team’s work to increase airflow reflects how committed we are to addressing pain points stemming from some Molekule review notes and consumer feedback. Our growth as a company has always been focused on addressing the gap in solutions for air quality. Our team is committed to continual improvement in our pursuit of cleaner air, and our technology reflects that. Air Pro has the same sleek and futuristic design as previous Air models. Molekule continues to push forward with new advances for better air purifying solutions with groundbreaking nanotechnology. Our cutting-edge technology has been praised for its ability to destroy viruses and mold. In laboratory tests, Molekule’s PECO technology destroyed over 99.947 percent of a proxy virus (MS2 bacteriophage) in one hour and destroyed over 99.999 percent in 24 hours. Testing has shown that Air reduces a single injection of particulate matter 0.3 to 1.0 micron in size by 85 percent in 22 minutes. The particles destroyed by Air can affect people’s health, especially those with asthma, allergies, and congestion. Molekule units are designed to be quiet and efficient in destroying pollutants, allergens, viruses, and other harmful particles. On the commercial side, Molekule created Air Pro RX in response to a clear need in medical settings. This larger Molekule unit has FDA-granted 510(k) Class II Medical Device Clearance and is intended for healthcare facilities, like clinics and hospitals. Air Pro RX utilizes the same PECO technology as the smaller Air units to destroy bacteria and viruses floating in the air. This is a common need for many healthcare providers that are looking for solutions to help increase safety for patients, employees, and visitors – especially in concentrated waiting rooms, heavy-traffic lobbies, ICUs, isolation units, and emergency departments. Our units do not produce ozone or disturb airflow, and each is rated to cover critical environments of up to 600 square feet. In addition to the Air Pro RX, the FDA has also granted Molekule’s Air Mini and Air Mini+ Class II medical device clearance for the destruction of viruses and bacteria. Developed for smaller spaces in healthcare environments and for medical use in the home, Air Mini and Air Mini+ were demonstrated to have greater than 5-log, or 99.999% reduction of RNA virus MS2, in just two hours. Our team remains committed to building technology-based solutions for a brighter, cleaner and clearer world.
Molekule began in San Francisco in 2014 with a vision to revolutionize air purification, and bring clean air to everyone, everywhere. Jaya Rao is our current CEO, and Dilip Goswami is president and CTO, and both of them are Molekule co-founders. As a child, Molekule co-founder Dilip Goswami had severe asthma and allergies. His father, Molekule co-founder Dr. Yogi Goswami, was frustrated by the lack of options for addressing poor indoor air quality. After more than 25 years of research and development, Dr. Goswami and his team decided to bring this groundbreaking technology to consumers for the first time. Both Goswami and Rao are Stanford engineers on a mission to provide better indoor air to everyone who needs it. Our breakthrough methods are fundamentally different from traditional filtration. Rather than trap particles in a filter, Molekule’s patented PECO technology destroys pollutants at the molecular level. Rigorous testing at a multitude of independent, third-party laboratories has carefully tracked and measured the destruction of particles by PECO technology. This is on top of the research Dr. Yogi Goswami did between 2006 and 2015 before helping found Molekule, when he published over 23 reports on this work. While many feel comfortable in their homes, the reality is that indoor air is often stagnant and full of particles. The World Health Organization has noted that 9 out of ten people throughout the world are breathing polluted air — indoors and out. Here at Molekule, we are on a mission to change the current realities for homes, businesses, schools, hospitals, the hospitality industry, and more. After more than 25 years of research and development work, Molekule has made even larger strides in PECO technology and air purification. In 2019, we launched Air Mini to provide a smaller standalone unit at a lower price point for rooms of less than 250 square feet. From dander particles to pollen, there are all kinds of tiny molecules that float in the air and get trapped in homes. In September 2020, we announced our new Air Pro purifier, which has increased airflow, six speed settings, and a particle sensor. The Molekule team’s work to increase airflow reflects how committed we are to addressing pain points stemming from some Molekule review notes and consumer feedback. Our growth as a company has always been focused on addressing the gap in solutions for air quality. Our team is committed to continual improvement in our pursuit of cleaner air, and our technology reflects that. Air Pro has the same sleek and futuristic design as previous Air models. Molekule continues to push forward with new advances for better air purifying solutions with groundbreaking nanotechnology. Our cutting-edge technology has been praised for its ability to destroy viruses and mold. In laboratory tests, Molekule’s PECO technology destroyed over 99.947 percent of a proxy virus (MS2 bacteriophage) in one hour and destroyed over 99.999 percent in 24 hours. Testing has shown that Air reduces a single injection of particulate matter 0.3 to 1.0 micron in size by 85 percent in 22 minutes. The particles destroyed by Air can affect people’s health, especially those with asthma, allergies, and congestion. Molekule units are designed to be quiet and efficient in destroying pollutants, allergens, viruses, and other harmful particles. On the commercial side, Molekule created Air Pro RX in response to a clear need in medical settings. This larger Molekule unit has FDA-granted 510(k) Class II Medical Device Clearance and is intended for healthcare facilities, like clinics and hospitals. Air Pro RX utilizes the same PECO technology as the smaller Air units to destroy bacteria and viruses floating in the air. This is a common need for many healthcare providers that are looking for solutions to help increase safety for patients, employees, and visitors – especially in concentrated waiting rooms, heavy-traffic lobbies, ICUs, isolation units, and emergency departments. Our units do not produce ozone or disturb airflow, and each is rated to cover critical environments of up to 600 square feet. In addition to the Air Pro RX, the FDA has also granted Molekule’s Air Mini and Air Mini+ Class II medical device clearance for the destruction of viruses and bacteria. Developed for smaller spaces in healthcare environments and for medical use in the home, Air Mini and Air Mini+ were demonstrated to have greater than 5-log, or 99.999% reduction of RNA virus MS2, in just two hours. Our team remains committed to building technology-based solutions for a brighter, cleaner and clearer world.
Molekule has raised $80.3M across 3 rounds. Its most recent round was a Venture - Series Unknown of $22.2M in Jun 2022. Full funding history, investors, and team are detailed below.
Funding history
3 rounds on record — latest round shown, the rest unlock with a paid plan.
Unlock 2 earlier rounds — dates, amounts, round types — plus the lead investor for every round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Molekule is featured in
Similar companies
Developing novel medical devices for marginalized groups is the main goal of PECA Labs. Our initial product, the Masa Valve, was developed by surgeons and engineers and then clinically implanted and validated. It will prevent countless children from undergoing open heart surgery every year. Despite the rigorous regulatory requirements that, for most businesses, have made the development of life-saving and life-sustaining (class III) medical devices cost-prohibitive for many pediatric conditions as well as the numerous rare, or "orphan," diseases that affect tens of millions of Americans and hundreds of millions of humans worldwide, PECA Labs' unique pathway will allow us to bring the Masa Valve through FDA approval. For an underserved market, PECA Labs provides a fully developed solution with a distinct value proposition.
Wildcat Discovery Technologies accelerates the discovery of new materials for energy applications, with a focus on the development of advanced materials for rechargeable and primary batteries. Wildcat’s business also includes collaborative development projects for materials for other applications, including gas storage, carbon capture, thermoelectrics, and structural materials. Wildcat synthesizes and evaluates thousands of materials every week. To do this, the company uses proprietary unique-in-the-world high throughput synthesis and testing platforms to rapidly explore thousands of new materials with the goal of improving performance and reducing costs. Wildcat employs an experienced team of scientists and engineers, with backgrounds in batteries, materials development, and high throughput automation. We also have a world class scientific advisory board. Wildcat is pursuing partnership and collaboration opportunities with corporate leaders throughout the battery supply chain, including global material suppliers, cell makers, and OEM’s throughout the automotive, electronics, medical, military, and consumer products industries.
Stoke Space is dedicated to developing the world's inaugural fully reusable medium-lift rocket, Nova, that offers affordable access to space. The company prioritizes sustainability by minimizing its atmospheric footprint and facilitating versatile space activities. Through its comprehensive design and production capacity, Stoke Space aims to propel the expansion of the space industry while promoting environmental responsibility.
Babyark is a manufacturing company that specializes in creating child car seats. Established in 2021, Babyark is based in Israel.
Dirac is a software for assembly automation that creates a platform for automated work instructions to enhance mechanical design. The company's goal is to improve American industry by offering innovative solutions that simplify and improve the production process. Its main product, BuildOS, generates accurate assembly work instructions from CAD files, enabling companies to easily move from design to production. Dirac is dedicated to bolstering the manufacturing sector in America by providing tools that improve efficiency, cut costs, and guarantee top productivity levels.
Soluna focuses on creating environmentally-friendly data centers for batch computing that utilize excess renewable energy.
Varda is a startup company in the field of space manufacturing that specializes in producing products in space for use on Earth. Their main goal is to create items in space that can take advantage of the effects of low gravity. The company plans to establish a system that extracts raw materials for new products through asteroid mining in space. In the future, Varda hopes to use these resources to produce pharmaceuticals, fiber optics, and other materials that benefit from the unique conditions in space. Their ultimate vision is to help build a sustainable space economy and expand human presence and operations beyond Earth.
Figma is a design platform for teams who build products together. Born in the browser, Figma helps the entire product team create, test, and ship better designs, faster. Whether you’re trying to consolidate tools, get more eyes on your work, or collaborate across time zones, Figma boosts creative productivity while keeping everyone on the same page. On a mission to make design accessible to all, Figma is helping companies like Airbnb, Slack, and Microsoft redesign how they design.
Copilot for Mechanical Engineers
Come work with us: https://foundation-alloy.rippling-ats.com/ Foundation Alloy integrates proprietary alloy design technology from MIT and UC Irvine, advanced manufacturing and automation to recast the metal parts manufacturing industry. FA metals can be fabricated into parts with less time, less energy, and better outcomes than legacy materials, and have superior mechanical properties than the current state of the art. By focusing on scalable, quality manufacturing, FA will provide the performance and production efficiency, flexibility & reliability necessary to unlock the next generations of industrial products. Backed by The Engine, Material Impact, Safar Partners and a host of others.
Knapsack offers a centralized platform for managing design and code choices for your product and brand, making it faster and easier to deliver improved experiences to the market. This fully remote, venture-backed startup team helps design and development teams create superior products in half the usual time.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.